by healthadvances Posted on January 13, 2023 Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook Read More
by healthadvances Posted on January 4, 2023 Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals Read More
by healthadvances Posted on December 21, 2022 Allogeneic Cell Therapy: ASH 2022 Takeaways and Future Outlook Read More
by healthadvances Posted on November 15, 2022 Let’s Talk About Vaginismus and Digital Health Read More
by healthadvances Posted on October 31, 2022November 1, 2022 Relyvrio Approval: Lessons Learned Read More
by healthadvances Posted on October 17, 2022 Ortho Summit 2022 – Chatting Cutting Edge MSK Innovation in Boston – Part 2 Read More
by healthadvances Posted on October 11, 2022October 17, 2022 Ortho Summit 2022 – Chatting Cutting Edge MSK Innovation in Boston – Part 1 Read More
by healthadvances Posted on September 23, 2022 Lessons Learned for Digital Women’s Health: Rock Health Summit 2022 Read More
by healthadvances Posted on July 21, 2022 Digital Biomarkers – The Future of Precision Medicine Read More
by healthadvances Posted on July 6, 2022July 21, 2022 Xenotransplantation: Market Disrupter or Expander? Read More
by healthadvances Posted on June 24, 2022June 24, 2022 From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology Read More
by healthadvances Posted on June 16, 2022June 16, 2022 ASCO 2022: Striving to Ensure No Patient is Left Behind Read More
by healthadvances Posted on May 4, 2022 Digital Health in Japan and Korea – Where Is It Heading? Read More
by healthadvances Posted on May 2, 2022 Opportunities and Challenges for Drug Makers in MDD Read More
by healthadvances Posted on February 25, 2022 Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases Read More
by healthadvances Posted on February 15, 2022 Women’s Health at Home: Reflections on a Rapidly Growing Space Read More
by healthadvances Posted on October 8, 2021 Building and Defending Markets; Reflections on Attending DTx and NASS Conferences Read More